Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy USANA Health Sciences stock

Learn how to easily invest in USANA Health Sciences stock.

USANA Health Sciences Inc is a household & personal products business based in the US. USANA Health Sciences shares (USNA) are listed on the NYSE and all prices are listed in US Dollars. USANA Health Sciences employs 1,943 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in USANA Health Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – USNA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

USANA Health Sciences stock price (NYSE: USNA)

Use our graph to track the performance of USNA stocks over time.

USANA Health Sciences shares at a glance

Information last updated 2022-01-17.
Latest market close$98.58
52-week range$80.00 - $107.85
50-day moving average $101.12
200-day moving average $98.90
Wall St. target price$104.00
PE ratio 15.4604
Dividend yield N/A (0%)
Earnings per share (TTM) $6.55

Buy USANA Health Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy USANA Health Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

USANA Health Sciences price performance over time

Historical closes compared with the close of $98.58 from 2022-01-20

1 week (2022-01-14) -2.64%
1 month (2021-12-21) -2.53%
3 months (2021-10-21) -1.73%
6 months (2021-07-21) -2.73%
1 year (2021-01-21) 15.12%
2 years (2020-01-21) 22.57%
3 years (2019-01-18) 118.97
5 years (2017-01-20) 59.77%

Is USANA Health Sciences stock undervalued or overvalued?

Valuing USANA Health Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of USANA Health Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

USANA Health Sciences's P/E ratio

USANA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, USANA Health Sciences shares trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

USANA Health Sciences's PEG ratio

USANA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0695. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into USANA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

USANA Health Sciences's EBITDA

USANA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $204.2 million.

The EBITDA is a measure of a USANA Health Sciences's overall financial performance and is widely used to measure a its profitability.

USANA Health Sciences financials

Revenue TTM $1.2 billion
Operating margin TTM 15.55%
Gross profit TTM $925.5 million
Return on assets TTM 20.67%
Return on equity TTM 34.46%
Profit margin 11.05%
Book value $20.31
Market capitalisation $2 billion

TTM: trailing 12 months

USANA Health Sciences share dividends

We're not expecting USANA Health Sciences to pay a dividend over the next 12 months.

Have USANA Health Sciences's shares ever split?

USANA Health Sciences's shares were split on a 2:1 basis on 22 November 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your USANA Health Sciences shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for USANA Health Sciences shares which in turn could have impacted USANA Health Sciences's share price.

USANA Health Sciences share price volatility

Over the last 12 months, USANA Health Sciences's shares have ranged in value from as little as $80 up to $107.85. A popular way to gauge a stock's volatility is its "beta".

USNA.US volatility(beta: 0.85)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while USANA Health Sciences's is 0.8459. This would suggest that USANA Health Sciences's shares are less volatile than average (for this exchange).

USANA Health Sciences overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine.

Frequently asked questions

What percentage of USANA Health Sciences is owned by insiders or institutions?
Currently 41.136% of USANA Health Sciences shares are held by insiders and 57.59% by institutions.
How many people work for USANA Health Sciences?
Latest data suggests 1,943 work at USANA Health Sciences.
When does the fiscal year end for USANA Health Sciences?
USANA Health Sciences's fiscal year ends in December.
Where is USANA Health Sciences based?
USANA Health Sciences's address is: 3838 West Parkway Boulevard, Salt Lake City, UT, United States, 84120
What is USANA Health Sciences's ISIN number?
USANA Health Sciences's international securities identification number is: US90328M1071
What is USANA Health Sciences's CUSIP number?
USANA Health Sciences's Committee on Uniform Securities Identification Procedures number is: 90328M107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site